Sarepta Therapeutics, Inc. ( SRPT) - Stock Earnings
SRPT Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 4, 2026, midnight | — / — | — | — / — | — |
SRPT Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -282.8 million USD | 442.9 million USD |
| 2026Q1 | 331.0 million USD | 730.8 million USD |
| 2026Q2 | -4.9 million USD | 401.3 million USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
SRPT Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -536.0 million USD | 1.2 billion USD |
| 2024 | 235.2 million USD | 1.9 billion USD |
| 2025 | -713.4 million USD | 2.2 billion USD |
| 2026 Est. | — | — |
SRPT
Price: $17.65
52 week price:
Earnings Per Share: -1.61 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 366531
Ebitda: -43.3 millionMarket Capitalization: 1.8 billion